Infusion Pump Software Market By Type (Drug Error Reduction Software (DERS), Interoperability, and Clinical Workflow), By Application (Hospitals and Ambulatory Care), Industry Trends, Estimation & Forecast, 2023-2030

Market Overview

Infusion pumps are controlled by software that administers user interface, controls the pumping mechanism to maintain the prescribed infusion rate and performs safety functions. The purpose of Infusion pump software is to make the device safer and easier to use. Infusion pump software can help reduce IV medication errors, track and measure system performance improve the overall quality of patient care, and help increase compliance with national safety standards.

Infusion Pump Software market was valued at 911.5 million US$ in 2022 and is projected to reach 1712.3 million US$ by 2030, at a CAGR of 8.2% during the forecast period.

Market Dynamics

The rise in the incidence of diabetes among the global population is one of the primary factors that influence the rapid software integration among insulin pump devices. According to the CDC, approximately 7% of France’s adult population, which is 45 million have diabetes. According to international diabetes federation, in 2017, there were over 7,476,800 cases of diabetes in Germany. Prevalence of diabetes in adults has increased to 12.2%. According to the World Health Organization (WHO), in 2016, almost 10% of adults in China which is about 110 million people have diabetes. The prevalence of diabetes in China is 10.9%. The increasing geriatric population has also increased sales of insulin pumps, in turn increasing the implementation of associated software. According to a report published by the World Population Ageing in 2017, the global population aged 60 years or over numbered 962 million in 2017. The number of elderly persons is expected to double again by 2050 when it is projected to reach nearly 2.1 billion. Furthermore, in 2030, older persons are expected to outnumber children under age 10 (1.41 billion versus 1.35 billion). Therefore, the rising prevalence of diabetes and increasing geriatric population would ensure the further sale of insulin pumps, incorporating extensive software adoption in such products. Moreover, Rapid technological development in software capabilities are key driving factors of the market. However, the connectivity of software solutions with insulin pump devices over network facilities requires investments for the up-gradation in the device as well as locally sourced network capabilities, which might pose a significant challenge of capital funding and procurement costs to some of the clinic facilities and individual patients. Rising adoption of data analytics in diabetes care would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global Infusion Pump Software market is mainly classified based on Type, Application. Type is further segmented into DERS, Interoperability, Clinical Workflow. By Application, the market is divided into Hospitals, Ambulatory Care.

Drug Error Reduction Software (DERS) was dominating the global Infusion Pump Software market by type in 2019. Drug Error Reduction Software incorporates a drug library with predefined upper and lower drug dose limits and infusion rates, which helps to reduce IV infusion errors. It helps to reduce IV medication errors and warning users. The increasing launch of new Infusion Pump Software, the partnership between companies to develop Infusion Pump Software and market, and regulatory approval of Infusion Pump Software with infusion pump are some of the factors boosting the market growth. For instance, Iradimed Corp. has received U.S. FDA 510(k) approval for MRidium 3860+ magnetic resonance imaging compatible IV infusion pump system, including its Dose Error Reduction System (DERS) software feature. The DERS software feature is designed for use with the MRidium 3860+ and incorporates the latestdosing safety features for patients. The system enables users to create a drug library and establish nominal values and limits for dose and concentration for specified infusion protocols.

Regional Analysis

Based on geography, the global Infusion Pump Software market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the global Infusion Pump Software market in 2019. The rising incidence of diabetes, increasing launch of new Infusion Pump Software, the partnership between companies to develop Infusion Pump Software and market, and regulatory approval of Infusion Pump Software with infusion pump are some of the factors boosting the North America Infusion Pump Software market. For instance, Baxter Canada has received Health Canada approval for the Spectrum IQInfusion System with Dose IQ Safety Software. The Spectrum IQ system has been integrated with new bi-directional electronic medical records (EMR) to help ensure the correct fluids and medications are delivered to the patient.

North America Infusion Pump Software market is estimated to grow at a CAGR of 7.8% till 2030.

Competitive landscape

Key players operating in the Infusion Pump Software industry include BD, ICU Medical, B. Braun, Moog, Baxter, Medtronic, Fresenius Kabi, Terumo Medical, Ypsomed, Smiths Medical, Micrel Medical Devices.

Regulatory approval of Infusion Pump Software, increasing launch of new software, the partnership between companies to develop and market new Software, and competitive advancement between companies to grow their market share for Infusion Pump Software are some of the key strategies adopted by the top companies. For instance, on January 23, 2020, Medtronic has introduced a cloud-based data management software platform for its Synchromed II drug delivery system. Efficio Management Software manages targeted drug delivery pump practices to treat patients. Efficio enables scheduling patient appointments, facilitates prescription drug order tracking for pump refills and print reports on demand.

Infusion Pump Software Market Key Segments

By Type
• DERS
• Interoperability
• Clinical Workflow

By Application
• Hospitals
• Ambulatory Care

Key Global Infusion Pump Software Industry Players

• BD
• ICU Medical
• B. Braun
• Moog
• Baxter
• Medtronic
• Fresenius Kabi
• Terumo Medical
• Ypsomed
• Smiths Medical
• Micrel Medical Devices

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. Infusion Pump Software Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Rising prevalence of diabetes and geriatric population
3.3.2. Rapid technological development in software capabilities
3.4. Restraints
3.4.1. High costs of device incorporation and software implementation
3.5. Opportunity
3.5.1. Rising adoption of data analytics in diabetes care
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis

4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. DERS
4.2.1. Market Size & Forecast
4.3. Interoperability
4.3.1. Market Size & Forecast
4.4. Clinical Workflow
4.4.1. Market Size & Forecast

5. Application Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Hospitals
5.2.1. Market Size & Forecast
5.3. Ambulatory Care
5.3.1. Market Size & Forecast

6. Infusion Pump Software Market Regional Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. North America Infusion Pump Software Market
6.2.1. North America Market Size & Forecast, By Country
6.2.2. North America Market Size & Forecast, By Type
6.2.3. North America Market Size & Forecast, By Application
6.2.4. The U.S.
6.2.4.1. Market Size and Forecast
6.2.5. Canada
6.2.5.1. Market Size and Forecast
6.2.6. Mexico
6.2.6.1. Market Size and Forecast
6.3. Europe Infusion Pump Software Market
6.3.1. Europe Market Size & Forecast, By Country
6.3.2. Europe Market Size & Forecast, By Type
6.3.3. Europe Market Size & Forecast, By Application
6.3.4. Germany
6.3.4.1. Market Size and Forecast
6.3.5. France
6.3.5.1. Market Size and Forecast
6.3.6. UK
6.3.6.1. Market Size and Forecast
6.3.7. Italy
6.3.7.1. Market Size and Forecast
6.3.8. Spain
6.3.8.1. Market Size and Forecast
6.3.9. Rest of Europe
6.3.9.1. Market Size and Forecast
6.4. Asia-Pacific Infusion Pump Software Market
6.4.1. Asia-Pacific Market Size & Forecast, By Country
6.4.2. Asia-Pacific Market Size & Forecast, By Type
6.4.3. Asia-Pacific Market Size & Forecast, By Application
6.4.4. Japan
6.4.4.1. Market Size and Forecast
6.4.5. China
6.4.5.1. Market Size and Forecast
6.4.6. Australia
6.4.6.1. Market Size and Forecast
6.4.7. India
6.4.7.1. Market Size and Forecast
6.4.8. South Korea
6.4.8.1. Market Size and Forecast
6.4.9. Rest of Asia-Pacific
6.4.9.1. Market Size and Forecast
6.5. South America Infusion Pump Software Market
6.5.1. South America Market Size & Forecast, By Country
6.5.2. South America Market Size & Forecast, By Type
6.5.3. South America Market Size & Forecast, By Application
6.5.4. Brazil
6.5.4.1. Market Size and Forecast
6.5.5. Argentina
6.5.5.1. Market Size and Forecast
6.5.6. Rest of South America
6.5.6.1. Market Size and Forecast
6.6. Middle East & Africa Infusion Pump Software Market
6.6.1. Middle East & Africa Market Size & Forecast, By Country
6.6.2. Middle East & Africa Market Size & Forecast, By Type
6.6.3. Middle East & Africa Market Size & Forecast, By Application
6.6.4. GCC Countries
6.6.4.1. Market Size and Forecast
6.6.5. Egypt
6.6.5.1. Market Size and Forecast
6.6.6. South Africa
6.6.6.1. Market Size and Forecast
6.6.7. Rest of Middle East & Africa
6.6.7.1. Market Size and Forecast

7. Company Profile
7.1. BD
7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2. BD Product Category, Application, and Specification
7.1.3. BD Financial Performance (2016-2018)
7.1.4. Main Business/Business Overview
7.2. ICU Medical
7.3. B. Braun
7.4. Moog
7.5. Baxter
7.6. Medtronic
7.7. Fresenius Kabi
7.8. Terumo Medical
7.9. Ypsomed
7.10. Smiths Medical
7.11. Micrel Medical Devices